Patents by Inventor Sandra CORAL

Sandra CORAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA HYPOMETHYLATING AGENTS FOR CANCER THERAPY
    Publication number: 20210338701
    Abstract: The present invention relates to a method of treating and/or preventing cancer comprising administering a combination of an effective amount of a DNA hypomethylating agent and an effective amount of at least one immunomodulatory agent and/or optionally an effective amount of at least one targeted therapy agent.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Inventors: Michele MAIO, Sandra CORAL, Alessia COVRE
  • DNA hypomethylating agents for cancer therapy
    Patent number: 11083743
    Abstract: The present invention relates to a method of treating and/or preventing cancer comprising administering a combination of an effective amount of a DNA hypomethylating agent and an effective amount of at least one immunomodulatory agent and/or optionally an effective amount of at least one targeted therapy agent.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: August 10, 2021
    Inventors: Michele Maio, Sandra Coral, Alessia Covre
  • DRUG COMBINATIONS
    Publication number: 20200009247
    Abstract: The invention provides combinations of derivatives of decitabine and other active agents, including T-cell activating agents, cancer vaccines, and adjuvants. Some derivatives of decitabine exhibit superior chemical stability and shelf life, with similar physiological activity. Methods of treating one or more myelodysplasia syndromes, cancers, haematological disorders, or diseases associated with abnormal haemoglobin synthesis using the combinations are described.
    Type: Application
    Filed: July 17, 2019
    Publication date: January 9, 2020
    Inventors: Mohammad AZAB, Pietro TAVERNA, Alessia COVRE, Sandra CORAL
  • DRUG COMBINATIONS
    Publication number: 20160015805
    Abstract: The invention provides combinations of derivatives of decitabine and other active agents, including T-cell activating agents, cancer vaccines, and adjuvants. Some derivatives of decitabine exhibit superior chemical stability and shelf life, with similar physiological activity. Methods of treating one or more myelodysplasia syndromes, cancers, haematological disorders, or diseases associated with abnormal haemoglobin synthesis using the combinations are described.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 21, 2016
    Inventors: Mohammad AZAB, Pietro TAVERNA, Alessia COVRE, Sandra CORAL
  • DNA HYPOMETHYLATING AGENTS FOR CANCER THERAPY
    Publication number: 20150374731
    Abstract: The present invention relates to a method of treating and/or preventing cancer comprising administering a combination of an effective amount of a DNA hypomethylating agent and an effective amount of at least one immunomodulatory agent and/or optionally an effective amount of at least one targeted therapy agent.
    Type: Application
    Filed: February 21, 2014
    Publication date: December 31, 2015
    Inventors: Sandra CORAL, Michele MAIO, Alessia COVRE